Cargando…

Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer

Detalles Bibliográficos
Autores principales: Ehmsen, Sidse, Asmussen, Anders, Jeppesen, Stefan S., Nilsson, Anna Christine, Kragh, Amalie, Frederiksen, Henrik, Ditzel, Henrik J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247283/
https://www.ncbi.nlm.nih.gov/pubmed/35803259
http://dx.doi.org/10.1016/j.ccell.2022.06.012
_version_ 1784739126528966656
author Ehmsen, Sidse
Asmussen, Anders
Jeppesen, Stefan S.
Nilsson, Anna Christine
Kragh, Amalie
Frederiksen, Henrik
Ditzel, Henrik J.
author_facet Ehmsen, Sidse
Asmussen, Anders
Jeppesen, Stefan S.
Nilsson, Anna Christine
Kragh, Amalie
Frederiksen, Henrik
Ditzel, Henrik J.
author_sort Ehmsen, Sidse
collection PubMed
description
format Online
Article
Text
id pubmed-9247283
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92472832022-07-01 Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer Ehmsen, Sidse Asmussen, Anders Jeppesen, Stefan S. Nilsson, Anna Christine Kragh, Amalie Frederiksen, Henrik Ditzel, Henrik J. Cancer Cell Letter Elsevier Inc. 2022-08-08 2022-07-01 /pmc/articles/PMC9247283/ /pubmed/35803259 http://dx.doi.org/10.1016/j.ccell.2022.06.012 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter
Ehmsen, Sidse
Asmussen, Anders
Jeppesen, Stefan S.
Nilsson, Anna Christine
Kragh, Amalie
Frederiksen, Henrik
Ditzel, Henrik J.
Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer
title Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer
title_full Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer
title_fullStr Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer
title_full_unstemmed Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer
title_short Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer
title_sort increased antibody titers and reduced seronegativity following fourth mrna covid-19 vaccination in patients with cancer
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247283/
https://www.ncbi.nlm.nih.gov/pubmed/35803259
http://dx.doi.org/10.1016/j.ccell.2022.06.012
work_keys_str_mv AT ehmsensidse increasedantibodytitersandreducedseronegativityfollowingfourthmrnacovid19vaccinationinpatientswithcancer
AT asmussenanders increasedantibodytitersandreducedseronegativityfollowingfourthmrnacovid19vaccinationinpatientswithcancer
AT jeppesenstefans increasedantibodytitersandreducedseronegativityfollowingfourthmrnacovid19vaccinationinpatientswithcancer
AT nilssonannachristine increasedantibodytitersandreducedseronegativityfollowingfourthmrnacovid19vaccinationinpatientswithcancer
AT kraghamalie increasedantibodytitersandreducedseronegativityfollowingfourthmrnacovid19vaccinationinpatientswithcancer
AT frederiksenhenrik increasedantibodytitersandreducedseronegativityfollowingfourthmrnacovid19vaccinationinpatientswithcancer
AT ditzelhenrikj increasedantibodytitersandreducedseronegativityfollowingfourthmrnacovid19vaccinationinpatientswithcancer